News
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...
The company filed for bankruptcy in 2022 and entered a restructuring agreement later that year.
1h
WATE 6 On Your Side on MSNThese Tennessee Big Lots stores will reopen in June: Here’s whereIt’s been five months since Big Lots announced it was preparing to close all of its stores, after closing hundreds of others ...
Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...
The acquisition marks a turning point for the company after months of financial uncertainty and data breach concerns.
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Monday that it has secured the winning bid in the bankruptcy auction ...
Explore more
Dow Jones Top Company Headlines at 7 PM ET: Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million | Jamie ... The DNA testing company would sell for a fraction of its peak valuation of $6 ...
ELMIRA, N.Y. (WETM) –Rite Aid filed for bankruptcy again, meaning that all of its stores must close or be bought by another ...
Regeneron is buying 23andMe for $256M in bankruptcy, gaining access to DNA data from 15 million users to aid drug research.
A widely followed market analyst is sounding the alarm about the surging number of large US companies going bankrupt this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results